Definitive Contract HR001122C0128
Award Date 8/26/22
Potential Completion Date 8/25/26
Potential Value $1.5M
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
Total Small Business
Extent Competed
Full and Open Competition after exclusion of sources
Major Defense Program
Not listed Pricing Type
Cost Plus Fixed Fee
Place of Performance
Rural Hall, NC 27099, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
2
Legislative Mandate
Employment Eligibility Verification
National Interest Action
Not listed Research Type
SBIR Program Phase II Action
Primary Consortia Member
Not listed Similar Awards
- This is a $2,999,998.63 Firm Fixed Price SBIR Direct to Phase II contract awarded by the Defense Health Agency (DHA) to Zymeron Corporation, a minority-owned small business located in Research Triangle Park, North Carolina. The contract is for the "Development for ShockDefender Against Hemorrhagic Shock" and was awarded from Proposal H2D-0119 under the DHA's Small Business Innovation Research (SBIR) program. The contract has a period of performance through January 14, 2026. Zymeron...
- This is a $1,249,946.00 Small Business Innovation Research (SBIR) Phase II award from the Defense Advanced Research Projects Agency (DARPA) to CCJ Medical Devices LLC, a veteran-owned limited liability company located in Asheville, North Carolina. The contract is for the development of an "Automated Partial Occlusion for Truncal Hemorrhage Control" technology, which was solicited under DARPA's Broad Agency Announcement for SBIR and Small Business Technology Transfer (STTR)...
- This is a Small Business Innovative Research (SBIR) Phase I contract awarded by the Defense Advanced Research Projects Agency (DARPA) to Autonomous Healthcare Inc., a for-profit Subchapter S corporation. The $224,459 Firm Fixed Price contract is for the development of an "Automated System for Hemorrhage Control and Resuscitation at Point of Injury", which aligns with DARPA's mission to provide game-changing capabilities to warfighters. The original solicitation was a Broad Agency...
- This is a Small Business Innovation Research (SBIR) Phase I contract awarded by the Defense Advanced Research Projects Agency (DARPA) to JSL Innovations LLC, a small business, for the development of an Automated Hemorrhage Control Device. The contract has a ceiling value of $218,930.00 and a period of performance ending on March 25, 2022. The award was made on May 28, 2021 under a Broad Agency Announcement that sought proposals for SBIR and Small Business Technology Transfer (STTR) funding...
- This is a Small Business Innovation Research (SBIR) Phase I contract awarded by the Defense Threat Reduction Agency (DTRA), a defense agency, to Zymeron Corporation, a minority-owned small business located in Research Triangle Park, North Carolina. The $149,933.01 firm-fixed-price contract is for research and development under the SBIR program, with a period of performance ending on January 11, 2018. Zymeron Corporation is a biotechnology company that specializes in innovative medical research...
- This is a firm-fixed-price purchase order contract awarded by the U.S. Army Research, Development and Engineering Command (RDECOM) to Zymeron Corporation, a minority-owned, for-profit biotechnology company, under the Small Business Innovation Research (SBIR) Program Phase I. The contract, valued at $197,000.00, is for research and development services related to an unspecified biomedical or public health initiative. As a total small business set-aside, this award aligns with Zymeron's...
- This $3 million firm-fixed-price contract was awarded by the Defense Health Agency (DHA) to Zymeron Corporation, a minority-owned small business, under the DHA's Small Business Innovation Research (SBIR) program. The contract supports the development of a "Rapid Sample Processing Device to Support Battlefield Wound Infection Diagnostics", aligning with the DHA's mission to provide innovative medical technologies for military healthcare. The contract has an ultimate completion date of...
- This is a firm fixed-price purchase order awarded to Zymeron Corporation, a minority-owned small business, under the Department of the Army Medical Command's Small Business Innovation Research (SBIR) program. The $250,000.00 Phase I contract is for the research and development of a "Novel Aerosol Therapy for Immediate and Sustained ARDS Management". Zymeron, a biotechnology company focused on areas like drug delivery systems, will perform this medical research at its facilities in...
- This contract was awarded by the Department of the Army Materiel Command TACOM Life Cycle Management Command to Zymeron Corporation, a minority-owned small business. The contract is for Phase I SBIR (Small Business Innovation Research) research, with a firm fixed-price contract type and a potential value of $162,482.83. Zymeron is a biotechnology company that focuses on developing innovative technologies in areas such as protein degradation, antibacterials, antivirals, and drug delivery systems....
- This is a $167,496.80 STTR Phase I contract awarded by the Department of the Army Materiel Command Research Development and Engineering Command to the minority-owned small business Zymeron Corporation. The contract is for research and development of innovative biotechnology solutions, including technologies related to protein degradation, antibacterials, antivirals, and drug delivery systems. Zymeron has experience providing medical research, engineering services, IT solutions, and biotech...